Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 4, 2010, Pages 306-318

  Davidson, Eric P ^a   Coppey, Lawrence J ^a   Calcutt, Nigel A ^b   Oltman, Christine L ^a,c   Yorek, Mark A ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Neuropathy; Neutral endopeptidase; Obesity; Vascular function

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; MEMBRANE METALLOENDOPEPTIDASE;

ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; ELECTROSTIMULATION; ENZYME ACTIVITY; GLUCOSE TOLERANCE; HYPOALGESIA; LIPID DIET; MALE; MICROANGIOPATHY; MOTOR NERVE CONDUCTION; MYELINATED NERVE; NERVE CONDUCTION; NERVE FIBER; NEUROLOGIC DISEASE; NOCICEPTION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SENSORY NERVE CONDUCTION; SENSORY NEUROPATHY; SPRAGUE DAWLEY RAT; VASODILATATION;

ANIMALS; ARTERIOLES; BLOOD GLUCOSE; BLOTTING, WESTERN; IMMUNOHISTOCHEMISTRY; NERVOUS SYSTEM DISEASES; OBESITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77952782622     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1088     Document Type: Article

References (64)

1. Caglayan E, Blaschke F, Takata Y, Hsueh WA. Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. Curr Opin Pharmacol 2005; 5: 135-142.
2. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabetic Med 2004; 21: 252-255.
3. de Jongh RT, Serne EH, IJzerman RG, de Vries G, Stehouwer SD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109: 2529-2535.
4. Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA. Progression of vascular and neural dysfunction in sciatic nerves of Zucker Diabetic Fatty (ZDF) and Zucker rats. Am J Physiol 2005; 289: E113-122.
5. LeRoith D, Rayfield EJ. The benefits of tight glycemic control in type 2 diabetic mellitus. Clin Cornerstone 2007; 8: S19-S29.
6. Jellinger PS. Metabolic consequences of hyperglycemia and insulin resistance. Clin Cornerstone 2007; 8: S30-S42.
7. Pilz S, Scharnagl H, Tiran B, et al. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 2006; 91: 2542-2547.
8. Bays H, Mandarino L, DeFronzo RA. Role of the adipocytes, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 2004; 89: 463-478.
9. Poynten AM, Gan SK, Kriketos AD, Campbell LV, Chisholm DJ. Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in non-diabetic men. J Clin Endocrinol Metab 2005; 90: 1035-1040.
10. Schaefer JR, Maisch B, Klumpp S, Krieglstein J. Why does atherosclerosis occur where it occurs? Atherosclerosis 2005; 180: 417-418.
11. Hufnagel B, Dworak M, Soufi M, et al. Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cβ and induce apoptosis in endothelial cells. Atherosclerosis 2005; 180: 245-254.
12. Ebrahimi R, Saleh JR, Toggart EJ, et al. Lipid lowering therapy in patients with peripheral arterial disease. J Cardiovasc Pharmacol Ther 2004; 9: 271-277.
13. Kim CK, Schmalfuss CM, Schofield RS, Sheps DS. Pharmacological treatment of patients with peripheral arterial disease. Drugs 2003; 63: 637-647.
14. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Yorek MA. Attenuation of vascular/neural dysfunction in Zucker rats treated with Enalapril or Rosuvastatin. Obesity 2008; 16: 82-89.
15. Mihara M, Uchiyama M, Fukuzama K. Thiobarbituric acid value of fresh homogenate of rat as a parameter of lipid peroxidation in aging, CC14 intoxication, and vitamin E deficiency. Biochem Med 1980; 23: 302-311. (Pubitemid 10086810)
16. Siman CM, Eriksson UJ. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia 1997; 40: 1416-1424.
17. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001; 50: 1927-1937. (Pubitemid 33641615)
18. Coppey LJ, Davidson EP, Rinehart TW, et al. ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2006; 55: 341-348.
19. Obrosova IG, Li F, Abatan OI, et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 2004; 53: 711-720.
20. Forcier NJ, Mizisin AP, Rimmer MA, Powell HC. Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropath Exp Neurol 1991; 50: 235-255.
21. Wattanapitayakul SK, Weinstein DM, Holycross BJ, Bauer JA. Endothelial dysfunction and peroxynitrite formation are early events in angiotensin-induced cardiovascular disorders. FASEB J 2000; 14: 271-278.
22. Pryor WA, Squadrito GI. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268: L699-L722.
23. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9: 836-844. (Pubitemid 126746860)
24. Davidson EP, Kleinschmidt TL, Oltman CL, Lund DD, Yorek MA. Treatment of streptozotocin-induced diabetic rats with AVE7688, a vasopeptidase inhibitor, on vascular and neural disease. Diabetes 2007; 56: 355-362.
25. Beiswenger KK, Calcutt NA, Mizisin AP. Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem 2008; 110: 351-362.
26. Ayoub S, Melzig MF. Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea. J Pharm Pharmacol 2006; 58: 495-501.
27. Terata K, Coppey LJ, Davidson EP, Dunlap JA, Gutterman DD, Yorek MA. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. British J Pharm 1999; 128: 837-843.
28. Yorek MA, Coppey LJ, Gellett JS, Davidson EP. Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin-gene related peptide (CGRP): effect of streptozotocin-induced diabetes. Exp Diabetes Res 2004; 5: 187-193.
29. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Yorek MA. Treatment of Zucker Diabetic Fatty rats with AVE7688 improves vascular and neural dysfunction. Diabetes Obes Metab 2009; 11: 223-233.
30. Tschop M, Heiman ML. Rodent obesity models: an overview. Expt Clin Endocrinol Diabetes 2001; 109: 307-319.
31. Singleton JR, Smith AG, Russell J, Feldman EL. Polyneuropathy with impaired glucose tolerance: implications for diagnosis and therapy. Curr Treat Options Neurol 2005; 7: 33-42. (Pubitemid 40220517)
32. Singleton JR, Smith AG, Bromberg MB. Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 2001; 24: 1448-1453. (Pubitemid 33716436)
33. Summer CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60: 108-111. (Pubitemid 36070653)
34. Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist 2008; 14: 23-29.
35. Perry TA, Weerasuriya A, Mouton PR, Holloway HW, Greig NH. Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy. Exp Neurol 2004; 190: 133-144.
36. Calcutt NA, Dines KC, Cesena RM. Effects of the peptide HP228 on nerve disorders in diabetic rats. Metabolism 1998; 47: 650-656.
37. Obrosova IG. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 2009; 6: 638-647.
38. Lauria G, Lombardi R, Borgna M, et al. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 2005; 10: 202-208.
39. Piriz J, Torres-Aleman I, Nunez A. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy. Neuroscience 2009; 160: 402-411.
40. Calcutt NA, Freshwater JD, Mizisin AP. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 2004; 47: 718-724.
41. Obrosova IG, Ilnytska O, Lyzogubov VV, Mashtalir N, Nadler JL, Drel VR. High-fat diet induced neuropathy of pre-diabetes and obesity: effect of "healthy" diet and aldose reductase inhibition. Diabetes 2007; 56: 2598-2608.
42. Beiswenger KK, Calcutt NA, Mizisin AP. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocindiabetic mice. Neurosci Lett 2008; 442: 267-272.
43. Yu LC, Hou JF, Fu FH, Zhang YX. Roles of calcitonin gene-related peptide and its receptor in pain-related behavioral responses in the central nervous system. Neurosci Biobehav Rev 2009; 33: 1185-1191.
44. Calcutt NA, Freshwater JD, Hauptmann N, Taylor EM, Mizisin AP. Protection of sensory function in diabetic rats by Neotrofin. Eur J Pharmacol 2006; 534: 187-193.
45. Davidson EP, Coppey LJ, Lu B, et al. The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy. Exp Diabetes Res in press.
46. Antezana MA, Sullivan SR, Usui ML, et al. Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J Invest Dermatol 2002; 119: 1400-1404.
47. Singleton JR, Smith AG, Bromberg MB Painful sensory neuropathy associated with impaired glucose tolerance. Muscle Nerve 2001; 24: 1225-1228.
48. Hoffman-Snyder C, Smith BE, Ross MA, Hernandez J, Bosch P. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy. Arch Neurol 2006; 63: 1075-1079.
49. Sugimoto K, Rashid IB, Kojima K, et al. Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia. Diabetes Metab Res Rev 2008; 24: 652-1650
50. Coppey LJ, Davidson EP, Dunlap JA, Lund DD, Yorek MA. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that provide circulation to the sciatic nerve. Int J Exp Diabetes Res 2000; 1: 131-143.
51. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Yorek MA. Changes in epineurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats. Diabetes Metab Res and Rev 2002; 18: 1-9.
52. Cameron NE, Cotter MA, Low PA. Nerve blood flow in early experimental diabetes in rats: relation to conduction defects. Am J Physiol 1991; 261: E1-E8.
53. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001; 37: 554-560. (Pubitemid 32199027)
54. Frank GD, Eguchi S, Motley ED. The role of reactive oxygen species in insulin signaling in the vasculature. Antioxidants and redox signaling 2005; 7: 1053-1061.
55. Iida S, Taguchi H, Watanabe N, Kushiro T, Kanmatsuse K. Insulin-induced relaxation of rat mesenteric artery is mediated by Ca(2+)-activated K(+) channels. Eur J Pharmacol 2001; 411: 155-160.
56. Oltman CL, Davidson EP, Coppey LJ, et al. Vascular and neural dysfunction in Zucker Diabetic Fatty rats: a difficult condition to reverse. Diabetes Obes Metab 2008; 10: 67-74.
57. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003; 24: 471-478.
58. Coppey LJ, Gellett JS, Davidson EP, Yorek MA. Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. Free Radical Res 2003; 37: 33-40.
59. Muangman P, Spenny ML, Tamura RN, Gibran NS. Fatty acids and glucose increase neutral endopeptidase activity in human microvascular endothelial cells. Shock 2003; 19: 508-512.
60. Pu Q, Schiffrin EL. Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats. Am J Hypertens 2001; 14: 1067-1072.
61. Katayama M, Nadel JA, Bunnett NW, Di Maria GU, Haxhiu M, Borson DB. Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides 1991; 12: 563-567.
62. Chauhan SD, Hobbs AJ, Ahluwalia A. C-type natriuretic peptide: new candidate for endothelium-derived hyperpolarizing factor. Int J Biochem Cell Biol 2004; 36: 1878-1881.
63. Naderali EK,Williams G. Effects of short-termfeeding of a highly palatable diet on vascular reactivity in rats. Euro J Clin Invest 2001; 31: 1024-1028. (Pubitemid 33754865)
64. Song GY, Gao Y, Di YW, Pan LL, Zhou Y, Ye JM. High-fat feeding reduces endothelium-dependent vasodilation in rats: differential mechanisms for saturated and unsaturated fatty acids? Clin Exp Pharmacol Physiol 2006; 33: 708-713.